The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Thrombosis Drugs Market Forecast up to 2024
US$ 3,250.00
... the growth of the market. Market Analysis: The “global thrombosis drugs market” is estimated to witness a CAGR of 9.5% during the forecast period 2018–2024. The market is analyzed based on three ...
January 2019
92 pages
Drug API Market - Forecasts from 2019 to 2024
US$ 3,800.00
... R&D expenditure, growing pharmaceutical industry is driving the growth of the global drug API market in the forecast period. A substance used in a finished pharmaceutical product (FPP), intended ...
January 2019
98 pages
Investigation Report on China's Recombinant Human Interferon ?2b Market, 2018-2022
US$ 2,200.00
... of China's Recombinant Human Interferon α2b market Major manufacturers of Recombinant Human Interferon α2b in China Prices of Recombinant Human Interferon α2b in China Major factors influencing development of Recombinant Human Interferon α2b in China Prospect of China's Recombinant Human Interferon α2b market ...
January 2019
30 pages
Drug Delivery Market - Forecasts from 2019 to 2024
US$ 3,800.00
... the growth of the global drug delivery market in the forecast period. Drug delivery systems/devices/technologies control the rate of drug release and the drug is released to a specific diseased ...
January 2019
114 pages
Global Inhalation And Nasal Spray Generic Drugs Industry Market Research Report
US$ 2,960.00
... of industrial development and characteristics of the Inhalation & Nasal Spray Generic Drugs market. The Inhalation & Nasal Spray Generic Drugs market can be split based ... major applications, and important regions. Major Players in Inhalation & Nasal Spray Generic Drugs market are: Sandoz (Novartis AG) Cipla ...
January 2019
125 pages
Global Antibacterial Drug Industry Market Research Report
US$ 2,960.00
... of industrial development and characteristics of the Antibacterial Drugs market. The Antibacterial Drugs market can be split based on product types, ... Introduction, Company Profiles, Market Distribution Status by Players of Antibacterial Drugs. Chapter 9: Antibacterial Drugs Market Analysis and Forecast by ...
January 2019
126 pages
Global Anti-Obesity Drugs Industry Market Research Report
US$ 2,960.00
The Anti-Obesity Drugs market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Ant...
January 2019
113 pages
Global Antiemetic Drugs Industry Market Research Report
US$ 2,960.00
The Antiemetic Drugs market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Antie...
January 2019
123 pages
Global Autoimmune Drug Industry Market Research Report
US$ 2,960.00
The Autoimmune Drug market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Autoim...
January 2019
107 pages
Global Vitamin A Palmitate Industry Market Research Report
US$ 2,960.00
The Vitamin A Palmitate market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Vi...
January 2019
106 pages
Global Vitamin D Analogs Industry Market Research Report
US$ 2,960.00
The Vitamin D Analogs market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Vita...
January 2019
131 pages
Global Vitamin E Nicotinate Industry Market Research Report
US$ 2,960.00
The Vitamin E Nicotinate market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the V...
January 2019
128 pages
Global Vitamin Ingredients Industry Market Research Report
US$ 2,960.00
The Vitamin Ingredients market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Vi...
January 2019
132 pages
Global Vitamin K1 Industry Market Research Report
US$ 2,960.00
The Vitamin K1 market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Vitamin K1...
January 2019
104 pages
Anti-Obesity Drugs: Market Research Report
US$ 5,450.00
This report analyzes the worldwide markets for Anti-Obesity Drugs in US$ Million. The report provides separate comprehensive analytics for the US, ... forecasts are provided for the period 2015 through 2024. Market data and analytics are derived from primary and secondary ...
January 2019
143 pages
Glycerin: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Glycerin in Thousand pounds by the following End-Use Applications: Pharmaceuticals & Personal ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
January 2019
252 pages
Proteomics: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
January 2019
261 pages
Carotenoids: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Carotenoids in both US$ Thousand and ... Canthaxanthin, Annatto, Capsanthin, and Others. Further, the market is analyzed by the following End-Use Applications in ... year historic analysis is provided for these markets. Market data and analytics are derived from primary ...
January 2019
487 pages
Endometriosis: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Endometriosis in US$ Million. The report provides separate comprehensive analytics for the US, ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
January 2019
181 pages
Orphan Drugs: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Orphan Drugs in US$ Million by the following Product Segments: Biologics, and Non-Biologics. ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
January 2019
436 pages
Investigation Report on China's Botulinum Toxin Type A Market, 2018-2022
US$ 2,200.00
... COVERED: Status of China's medical beauty market Sales of Botulinum Toxin Type A in China Competition on China's Botulinum Toxin Type A market Major factors influencing the development of China's Botulinum Toxin Type A market Prospect of China's Botulinum Toxin Type A market from 2018 ...
January 2019
30 pages
Investigation Report on China's Fibrin Sealant (Human) Market, 2018-2022
US$ 2,200.00
... operations in China Status of China's Fibrin Sealant (Human) market Competition on China's Fibrin Sealant (Human) market Prices of Fibrin Sealant (Human) in China Factors influencing the development of China's Fibrin Sealant (Human) market Prospect of China's Fibrin Sealant (Human) market ...
January 2019
30 pages
Investigation Report on China's Hydrotalcite Market, 2018-2022
US$ 2,200.00
... : Situation of gastrointestinal diseases in China Status of China's Hydrotalcite market Competition on China's Hydrotalcite market Prices of Hydrotalcite in China Major factors influencing the development of China's Hydrotalcite market Prospect of China's Hydrotalcite market, 2018-2022
January 2019
30 pages
Investigation Report on China's Recombinant Human Follitropin Market, 2018-2022
US$ 2,200.00
... in China Status of China's Recombinant Human Follitropin market Competition on China's Recombinant Human Follitropin market Prices of Recombinant Human Follitropin in China Factors influencing the development of China's Recombinant Human Follitropin market Prospect of China's Recombinant Human Follitropin ...
January 2019
30 pages
Abilify- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Abilify ...
January 2019
35 pages
Aciphex- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Aciphex ...
January 2019
35 pages
Acthar Gel- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Acthar Gel ...
January 2019
35 pages
Adderall- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Adderall ...
January 2019
35 pages
Advair Diskus- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Advair Diskus ...
January 2019
35 pages
alimta- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of alimta ...
January 2019
35 pages
Ambisome- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Ambisome ...
January 2019
35 pages
Amitiza- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Amitiza ...
January 2019
35 pages
Angiox- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Angiox ...
January 2019
35 pages
Atripla- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Atripla ...
January 2019
35 pages
Avastin- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Avastin ...
January 2019
35 pages
Axiron- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Axiron ...
January 2019
35 pages
Azilect - Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Azilect ...
January 2019
35 pages
Azor- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Azor ...
January 2019
35 pages
Baraklyud- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Baraklyud ...
January 2019
35 pages
BeneFIX - Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of BeneFIX ...
January 2019
35 pages
Bepanthene- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Bepanthene ...
January 2019
35 pages
Betaseron- Drug Insight, 2019
US$ 1,000.00
... Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2019-2021 Market competition and emerging therapies SWOT Analysis REASONS TO BUY Establish a comprehensive understanding of Betaseron ...
January 2019
35 pages
